Pharma Technology Focus is a new monthly digital magazine offering in-depth and timely coverage of the pharmaceutical industry. Focusing on a special theme within the industry every month, the magazine combines a mix of editorial articles with integrated interactive features and video content in a ground-breaking digital format.
In this issue we focus on drug discovery and development. We investigate why open innovation is crucial in the development of ever more complex drugs for the most challenging medical and clinical problems. We also look at new drugs and current research, and explore how IT solutions can help companies achieve clinical trial results quicker and more cost-effective.
To read your free copy, click here.
Open the Treasure Chest
Confronted with increasingly challenging clinical and medical problems, the pharmaceutical industry is facing huge pressure to develop more complex drugs. But no organisation is capable of doing this on its own. Dr Paul Stoffels of Johnson & Johnson tells us why open innovation – the collaboration between big pharma, biotech and academic institutions – is the way forward.
BBMRI: The Industry Perspective
The Biobanking and Biomolecular Resources Research Infrastructure is paving the way for research cooperation in Europe. We talk to Dr David Cox of Pfizer to find out how big pharma is getting involved in a project that could revolutionise medical research.
Hope on the Horizon?
Treatment for HIV / Aids is more sophisticated than ever, but how much closer are we to finding a cure? We investigate the colossal challenges for organisations trying to treat, prevent, and eventually find a cure for the world’s most feared virus.
The Rise of Cannabinoid Medicine
A group of compounds found in the cannabis plant could herald a new wave of medical breakthroughs. We talk to GW Pharmaceuticals executive chairman Dr Geoffrey Guy about their new cannabis-derived drug Sativex and the future of cannabinoid research.
Trial and Error: Finding Focus with Clinical IT
Leveraging technology to streamline the clinical trial process is beneficial to big pharma and the patients it serves. We look into the new digital horizon for drug development.
Evolution of the Robot Scientist
In the increasingly competitive, global and high-expense world of drug discovery and development, HTS and HCS have been a vital part of the pharmaceutical company’s armoury for some time. As the science around automation and robotics becomes ever more advanced, their importance is on the rise, as we learn from robotics pioneer Dr Ross King.
Next Issue: Supply Chain & Logistics
The pharmaceutical industry faces unique challenges in logistics and supply chain management. Delays or disruptions do not only affect profits – they can be a matter of life and death.
Next month we look behind the scenes of the massive operation of getting the drug to the patient. We talk to industry experts about their risk management strategies and find out how companies can develop robust delivery strategies.
We also examine the growing role of IT in supply chain management and investigate how scientist and packaging experts work on new ways to overcome the limitations of pharmaceutical cold chains.
Digital Magazine FAQ
The digital magazine is viewable on any computer with Flash Player installed. It is also viewable on mobile devices, iPhones and iPads, although some features and videos may be disabled.
To view the online magazine, click here.